IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 153 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $573,000 | +116.2% | 42,400 | +66.0% | 0.00% | – |
| Q4 2018 | $265,000 | -95.7% | 25,543 | -92.4% | 0.00% | -100.0% |
| Q3 2018 | $6,235,000 | +71.9% | 337,743 | +78.0% | 0.01% | +40.0% |
| Q2 2018 | $3,628,000 | +386.3% | 189,766 | +292.4% | 0.01% | +400.0% |
| Q1 2018 | $746,000 | -25.3% | 48,366 | -27.5% | 0.00% | 0.0% |
| Q4 2017 | $999,000 | -84.4% | 66,666 | -83.6% | 0.00% | -90.0% |
| Q3 2017 | $6,422,000 | +739.5% | 407,216 | +714.4% | 0.01% | +900.0% |
| Q4 2016 | $765,000 | – | 50,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 16,390,000 | $157,835,700 | 21.26% |
| AlphaCentric Advisors LLC | 292,500 | $2,816,775 | 1.60% |
| Quantedge Capital Pte Ltd | 179,900 | $1,732,437 | 0.94% |
| Intrinsic Value Partners, LLC | 50,355 | $484,919 | 0.62% |
| Brown Capital Management | 3,719,796 | $35,821,635 | 0.55% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $33,281,280 | 0.51% |
| SummerHaven Investment Management, LLC | 67,765 | $652,577 | 0.48% |
| BRAIDWELL LP | 1,348,099 | $12,982,193 | 0.41% |
| AFFINITY INVESTMENT ADVISORS, LLC | 50,733 | $488,559 | 0.32% |
| EMC Capital Management | 43,315 | $417 | 0.31% |